K191179 is an FDA 510(k) clearance for the Myo Plus. This device is classified as a Electrode, Cutaneous (Class II - Special Controls, product code GXY).
Submitted by Otto Bock Healthcare Products GmbH (Vienna, AT). The FDA issued a Cleared decision on September 4, 2019, 125 days after receiving the submission on May 2, 2019.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1320.
| 510(k) Number | K191179 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | May 02, 2019 |
| Decision Date | September 04, 2019 |
| Days to Decision | 125 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GXY - Electrode, Cutaneous |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.1320 |